CD163 and neoplasm: In a comparative study involving 20 samples each of Ewing sarcoma and osteosarcoma, the median percentage of CD163+/CD68+ M2‐polarized TAMs was approximately 3% of the tumor area in Ewing sarcoma, notably lower than the ∼15% observed in osteosarcoma [412].